home / stock / aort / aort news


AORT News and Press, Artivion Inc Com From 11/06/25

Stock Information

Company Name: Artivion Inc Com
Stock Symbol: AORT
Market: NYSE
Website: artivion.com

Menu

AORT AORT Quote AORT Short AORT News AORT Articles AORT Message Board
Get AORT Alerts

News, Short Squeeze, Breakout and More Instantly...

AORT - Expected US Company Earnings on Thursday, November 6th, 2025

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

AORT - Artivion to Participate in the Stifel 2025 Healthcare Conference

Artivion to Participate in the Stifel 2025 Healthcare Conference PR Newswire ATLANTA , Oct. 29, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT),  a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the u...

AORT - Osterweis Opportunity Fund Q3 2025 Picks: AI Foundational Infrastructure Companies

2025-10-29 04:30:00 ET The following segment was excerpted from Osterweis Capital Management Q3 2025 Small Cap Growth Update. ... Read the full article on Seeking Alpha For further details see: Osterweis Opportunity Fund Q3 2025 Picks: AI Fou...

AORT - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results PR Newswire ATLANTA , Oct. 23, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced toda...

AORT - Edwards Lifesciences: Inflection Incoming, But When?

2025-10-14 14:36:29 ET Company Background Edwards Lifesciences Corporation ( EW ) was founded in 1958 and is based in Irvine, CA. It is a leader in designing and commercializing innovative technologies for the treatment of advanced cardiovascular diseases. Its main products ...

AORT - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting PR Newswire 30-day Data from the AMDS PERSEVERE Trial Demonstrates Visceral Malperfusion Resolution ...

AORT - Outperform Recommendation Issued On AORT By Citigroup

2025-10-10 08:15:08 ET Citigroup analyst issues OUTPERFORM recommendation for AORT on October 10, 2025 10:57AM ET. The previous analyst recommendation was Outperform. AORT was trading at $40.35 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

AORT - Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

2025-09-10 17:03:07 ET Artivion, Inc. (AORT) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT... Read the full article on Seeking Alpha For further details see: Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthca...

AORT - Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire ATLANTA , Sept. 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that ...

AORT - Share Growth And Strong Clinical Results Continue To Support The Artivion Story

2025-09-03 07:47:55 ET I can’t complain about the performance of Artivion ’s ( AORT ) share price since my last update. Even in an environment that hasn’t been particularly supportive for med-tech, shares of this small cap cardiology med-tech have risen near...

Previous 10 Next 10